Suzanne Ildstad insider trades: Talaris Therapeutics (TALS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Suzanne reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | TALS | ↓ Sell | 44,020 | $2.55 | $112K | Direct | Jun 14, 2023 (0d) |
| Jun 9, 2023 | TALS | ↓ Sell | 141,062 | $2.43 | $343K | Direct | Jun 9, 2023 (0d) |
| Jun 6, 2023 | TALS | ↓ Sell | 33,390 | $2.53 | $84K | Direct | Jun 7, 2023 (1d) |
| Jun 2, 2023 | TALS | ↓ Sell | 31,531 | $2.53 | $80K | Direct | Jun 5, 2023 (3d) |
| Apr 21, 2023 | TALS | ↓ Sell | 15,004 | $2.35 | $35K | Direct | Apr 25, 2023 (4d) |
| Apr 20, 2023 | TALS | ↓ Sell | 68,743 | $2.27 | $156K | Direct | Apr 21, 2023 (1d) |
| Apr 18, 2023 | TALS | ↓ Sell | 148,982 | $2.14 | $319K | Direct | Apr 19, 2023 (1d) |
| Mar 17, 2023 | TALS | ↓ Sell | 10,436 | $2.06 | $22K | Direct | Mar 20, 2023 (3d) |
| Mar 3, 2023 | TALS | ↓ Sell | 6,806 | $2.06 | $14K | Direct | Mar 7, 2023 (4d) |
| Mar 1, 2023 | TALS | ↓ Sell | 29 | $2.05 | $59 | Direct | Mar 2, 2023 (1d) |
| Feb 21, 2023 | TALS | ↓ Sell | 3,500 | $2.05 | $7K | Direct | Feb 23, 2023 (2d) |
| Feb 17, 2023 | TALS | ↓ Sell | 6,551 | $2.05 | $13K | Direct | Feb 21, 2023 (4d) |
| Aug 22, 2022 | TALS | ↓ Sell | 525,000 | $2.80 | $1.5M | Direct | Aug 23, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Suzanne Ildstad's insider trades
Suzanne Ildstad is a director at Talaris Therapeutics (TALS). Since Aug 22, 2022, Suzanne has reported no open-market purchases and 13 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TALS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.